EcoDrugPlus

Melatonin Receptor 1a A

Ensembl ID : ENSOTSG00005001370
Gene Symbol: MTNR1AA
1 Cross references
179 Possible Orthologues:

Melatonin Receptor 1a A

Ensembl ID : ENSOTSG00005006713
Gene Symbol: MTNR1AA
1 Cross references
180 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSOTSG00005013152
Gene Symbol: MME
1 Cross references
228 Possible Orthologues:

Metabotropic Glutamate Receptor 2-Like

Ensembl ID : ENSOTSG00005041062
Gene Symbol: LOC112244839
3 Cross references
200 Possible Orthologues:

Metabotropic Glutamate Receptor 3-Like

Ensembl ID : ENSOTSG00005029173
Gene Symbol: LOC112252440
3 Cross references
207 Possible Orthologues:

Metabotropic Glutamate Receptor 3-Like

Ensembl ID : ENSOTSG00005028769
Gene Symbol: LOC112252440
3 Cross references
207 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSOTSG00005002179
Gene Symbol: METAP2
1 Cross references
215 Possible Orthologues:

Methionyl Aminopeptidase 2b

Ensembl ID : ENSOTSG00005010282
Gene Symbol: METAP2B
1 Cross references
215 Possible Orthologues:

Microtubule-Associated Protein Tau-Like

Ensembl ID : ENSOTSG00005044044
Gene Symbol: LOC112223803
2 Cross references
206 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSOTSG00005025834
Gene Symbol: MAPK1
1 Cross references
208 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSOTSG00005035107
Gene Symbol: LOC112219617
3 Cross references
82 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSOTSG00005004813
Gene Symbol: MAPK10
1 Cross references
81 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).